Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: A cautionary tale

Emerging Themes in Epidemiology

Volumn 4, Issue , 2007, Pages

  Wilk, Jemma B ^a   Lash, Timothy L ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIVITAMIN;

ADULT; CIGARETTE SMOKING; COFFEE; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PARKINSON DISEASE; REVIEW; RISK FACTOR; SIBLING RELATION;

EID: 34247479386     PISSN: None     EISSN: 17427622     Source Type: Journal    
DOI: 10.1186/1742-7622-4-1     Document Type: Review

References (23)

1. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. YJ Li SA Oliveira P Xu ER Martin JE Stenger CR Scherzer MA Hauser WK Scott GW Small MA Nance RL Watts JP Hubble WC Koller R Pahwa MB Stern BC Hiner J Jankovic CG Goetz F Mastaglia LT Middleton AD Roses AM Saunders DE Schmechel SR Gullans JL Haines JR Gilbert JM Vance MA Pericak-Vance C Hulette KA Welsh-Bohmer, Hum Mol Genet 2003 12 3259 3267 10.1093/hmg/ddg357 14570706
2. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. ME Blomqvist PA Silburn DD Buchanan N Andreasen K Blennow NL Pedersen AJ Brookes GD Mellick JA Prince, Neurogenetics 2004 5 115 119 10.1007/s10048-004-0173-4 15088150
3. Introduction to Epidemiologic Thinking. KJ Rothman, Epidemiology: An Introduction New York: Oxford University Press, Inc 2002 5 6
4. Do right-handers live longer? DF Halpern S Coren, Nature 1988 333 213 10.1038/333213b0 3367996
5. Handedness and life span. DF Halpern S Coren, New Engl J Med 1991 324 998 2002827
6. Left-handedness and life expectancy (letter). KJ Rothman, N Engl J Med 1991 325 1041 1886627
7. Left-handedness and life expectancy (letter). PA Wolf RB D'Agostino J Cobb, N Engl J Med 1991 325 1042
8. Left-handedness and mortality. ME Salive JM Guralnik RJ Glynn, Am J Public Health 1993 83 265 267 8427338
9. Handedness and mortality: A follow-up study of Danish twins born between 1900 and 1910. O Basso J Olsen N Holm A Skytthe JW Vaupel K Christensen, Epidemiology 2000 11 576 580 10.1097/00001648-200009000-00014 10955411
10. Epidemiologic approaches to the study of Parkinson's disease etiology. H Checkoway LM Nelson, Epidemiology 1999 10 327 336 10.1097/00001648-199905000- 00023 10230846
11. Genome-wide scan for Parkinson's disease: the GenePD Study. AL DeStefano LI Golbe MH Mark AM Lazzarini NE Maher M Saint-Hilaire RG Feldman M Guttman RL Watts O Suchowersky AL Lafontaine N Labelle MF Lew CH Waters JH Growdon C Singer LJ Currie GF Wooten P Vieregge PP Pramstaller C Klein JP Hubble M Stacy E Montgomery ME MacDonald JF Gusella RH Myers, Neurology 2001 57 1124 1126 11571351
12. Complete genomic screen in Parkinson disease: evidence for multiple genes. WK Scott MA Nance RL Watts JP Hubble WC Koller K Lyons R Pahwa MB Stern A Colcher BC Hiner J Jankovic WG Ondo FH Allen Jr CG Goetz GW Small D Masterman F Mastaglia NG Laing JM Stajich B Slotterbeck MW Booze RC Ribble E Rampersaud SG West RA Gibson LT Middleton AD Roses JL Haines BL Scott JM Vance MA Pericak-Vance, JAMA 2001 286 2239 2244 10.1001/jama.286.18.2239 11710888
13. Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci. N Pankratz SK Uniacke CA Halter A Rudolph CW Shults PM Conneally T Foroud WC Nichols Parkinson Study Group, Neurology 2004 62 1616 1618 15136695
14. Environmental, Medical, and Family History Risk Factors for Parkinson's Disease: A New England-Based Case Control Study. CA Taylor MH Saint-Hilaire LA Cupples CA Thomas AE Burchard RG Feldman RH Myers, Am J Med Genet 1999 88 742 749 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-# 10581500
15. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's Disease. MA Hernan B Takkouche F Caamano-Isorna JJ Gestal-Otero, Ann Neurol 2002 52 276 284 10.1002/ana.10277 12205639
16. Neuroprotection by caffeine and A (2A) adenosine receptor inactivation in a model of Parkinson's Disease. J-F Chen K Xu JP Petzer R Staal Y-H Xu M Beilstein PK Sonsalla K Castagnoli N Castagnoli Jr MA Schwarzschild, J Neurosci 2001 21 10 RC143 11319241
17. Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methly-4-phenyl-1,2,3,6-tetrahydropyriding Parkinsonian toxin. K Parain C Hapdey E Rousselet V Marchand B Dumery EC Hirsch, Brain Res 2003 984 224 232 10.1016/S0006-8993(03)03195-0 12932857
18. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease. J De Reuck M De Weweire G Van Maele P Santens, J Neurol Sci 2005 231 35 39 10.1016/j.jns.2004.12.003 15792818
19. Limitations of the case-only design for identifying gene-environment interactions. PS Albert D Ratnasinghe J Tangrea S Wacholder, Am J Epidemiol 2001 154 687 693 10.1093/aje/154.8.687 11590080
20. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. NM Gatto UB Campbell AG Rundle H Ahsan, Int J Epidemiol 2004 33 1014 1024 10.1093/ije/dyh306 15358745
21. Epidemiologic Study of 203 Sibling Pairs with Parkinson's Disease: The Gene PD Study. NE Maher LI Golbe AM Lazzarini MH Mark LJ Currie GF Wooten M Saint-Hilaire JB Wilk J Volcjak JE Maher RG Feldman M Guttman M Lew S Schuman O Suchowersky AL Lafontaine N Labelle P Vieregge PP Pramstaller C Klein J Hubble C Reider J Growdon R Watts E Montgomery K Baker C Singer M Stacy RH Myers, Neurology 2002 58 79 84 11781409
22. NHLBI Family Heart Study: Objectives and Design. M Higgins M Province G Heiss J Eckfeldt RC Ellison AR Folsom DC Rao JM Sprafka R Williams, Am J Epidemiol 1996 143 1219 28 8651220
23. Average Age at First Occurrence as an Alternative Occurrence Parameter in Epidemiology. HC Boshuizen S Greenland, Int J Epidemiol 1997 26 867 872 10.1093/ije/26.4.867 9279621